Wasatch Advisors’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-68,992
| Closed | -$5.13M | – | 262 |
|
|
2020
Q3 | $5.13M | Sell |
68,992
-12,343
| -15% | -$918K | 0.03% | 201 |
|
|
2020
Q2 | $6.93M | Sell |
81,335
-26,118
| -24% | -$2.23M | 0.05% | 179 |
|
|
2020
Q1 | $7.77M | Sell |
107,453
-39,775
| -27% | -$2.88M | 0.08% | 145 |
|
|
2019
Q4 | $10.1M | Buy |
147,228
+76,629
| +109% | +$5.24M | 0.08% | 156 |
|
|
2019
Q3 | $3.71M | Sell |
70,599
-14,435
| -17% | -$758K | 0.04% | 213 |
|
|
2019
Q2 | $4.57M | Sell |
85,034
-12,423
| -13% | -$667K | 0.04% | 189 |
|
|
2019
Q1 | $6.93M | Buy |
97,457
+93,774
| +2,546% | +$6.67M | 0.08% | 143 |
|
|
2018
Q4 | $294K | Sell |
3,683
-4,041
| -52% | -$323K | ﹤0.01% | 226 |
|
|
2018
Q3 | $3.6M | Sell |
7,724
-130
| -2% | -$60.6K | 0.04% | 197 |
|
|
2018
Q2 | $3.12M | Buy |
7,854
+660
| +9% | +$262K | 0.04% | 193 |
|
|
2018
Q1 | $2.2M | Sell |
7,194
-1,027
| -12% | -$314K | 0.03% | 215 |
|
|
2017
Q4 | $2.42M | Buy |
8,221
+4,124
| +101% | +$1.21M | 0.03% | 210 |
|
|
2017
Q3 | $2.24M | Sell |
4,097
-49
| -1% | -$26.8K | 0.03% | 231 |
|
|
2017
Q2 | $2.47M | Buy |
4,146
+1,656
| +67% | +$987K | 0.03% | 225 |
|
|
2017
Q1 | $1.07M | Sell |
2,490
-2
| -0.1% | -$859 | 0.02% | 302 |
|
|
2016
Q4 | $1.28M | Hold |
2,492
| – | – | 0.02% | 299 |
|
|
2016
Q3 | $1.07M | Sell |
2,492
-43
| -2% | -$18.4K | 0.02% | 303 |
|
|
2016
Q2 | $1.06M | Buy |
+2,535
| New | +$1.06M | 0.02% | 314 |
|